FDA Inspection
Teva API India Ltd- MalanpurTeva API India Ltd- Malanpur – FDA Inspection, Apr 16, 2019
Record Details
This FDA Inspection record concerns Teva API India Ltd- Malanpur, with an inspection on April 16, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · aefd3fb2-1a56-4e93-922a-15b4e657e5fe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1086616
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Teva API India Ltd- Malanpur
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 15, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva API India Ltd- Malanpur
- FDA Inspection 1155847 - 2019-11-28
- FDA Inspection 1049573 - 2018-03-15
- FDA Inspection 929669 - 2015-04-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.